5432752026-09-242026-09-245432752026-09-245432752026-09-242026-09-24PartiesOfTheAgreementDomain15432752026-09-24PartiesOfTheAgreementDomain1xbrli:purexbrli:sharesAnupam Rasayan India LimitedANURASNewOthersExecution of certain security documentsExecution of agreementListed Entityfalse2026-09-2321:00:00true2026-09-24The agreement records the terms, conditions and stipulations for the issue, redemption and payment of debenture outstandings in respect of up to INR 300 crore senior, secured, unrated, unlisted, redeemable, non-convertible debentures proposed to be issued by Mates Visa Consultancy Private Limited (MVCPL) on a private placement basis (MVCPL Debentures). The proceeds are to be used for the acquisition of securities of Bliss GVS Pharma Limited by MVCPL, payment of costs, fees and expenses in connection with the debenture issue, and general corporate purposes. MVCPL intends to raise the balance funds for the acquisition of securities of Bliss GVS Pharma Limited through proceeds of issuance of equity-like instruments to Purebliss Pharma Solutions Private Limited.2026-09-17trueNo1Mates Visa Consultancy Private LimitedParty entering into the agreementMates Visa Consultancy Private Limited is a wholly-owned subsidiary of the Company. The Company does not have any shareholding in Catalyst Trusteeship Limited (MVCPL Debenture Trustee).00false2026-09-23The agreement records the terms, conditions and stipulations for the issue, redemption and payment of debenture outstandings in respect of up to INR 300 crore senior, secured, unrated, unlisted, redeemable, non-convertible debentures proposed to be issued by Mates Visa Consultancy Private Limited (MVCPL) on a private placement basis (MVCPL Debentures). The proceeds are to be used for the acquisition of securities of Bliss GVS Pharma Limited by MVCPL, payment of costs, fees and expenses in connection with the debenture issue, and general corporate purposes. MVCPL intends to raise the balance funds for the acquisition of securities of Bliss GVS Pharma Limited through proceeds of issuance of equity-like instruments to Purebliss Pharma Solutions Private Limited.The MVCPL Debentures are senior, secured, unrated, unlisted, redeemable, non-convertible debentures issued in dematerialised form on a private placement basis. The maximum tenor is 48 months from the deemed date of allotment, and the maturity date is the date falling at the end of 48 months from the deemed date of allotment.falseThe transaction is a financing arrangement through privately placed senior, secured, unrated, unlisted, redeemable nonconvertible debentures issued by Mates Visa Consultancy Private Limited (MVCPL). MVCPL is the borrower, and the debenture holders are lenders. The total issue size is up to INR 300 crore, and the amount outstanding at any time will be the relevant debenture outstandings, including principal, accrued coupon, additional coupon, default charges, make-whole amounts, remuneration and costs. The security comprises, inter alia, hypothecation over MVCPL’s assets, pledge over the securities of MVCPL held by the Company, corporate guarantee by the Company, personal guarantees and any other agreed security interests.